These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16871080)

  • 1. First human exposure to Org 25969.
    Nigrovic V; Bhatt SB; Amann A
    Anesthesiology; 2006 Aug; 105(2):427; author reply 427. PubMed ID: 16871080
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
    de Boer HD; Driessen JJ; van Egmond J; Booij LH
    Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
    [No Abstract]   [Full Text] [Related]  

  • 3. Sugammadex-rocuronium dosing.
    Kopman AF
    Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
    [No Abstract]   [Full Text] [Related]  

  • 4. Rocuronium and sugammadex in myotonic dystrophy.
    Baumgartner P
    Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
    [No Abstract]   [Full Text] [Related]  

  • 5. The concept behind sugammadex.
    Epemolu O; Bom A
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sugammadex use experience in pediatric oncology].
    Matinyan NV; Saltanov AI; Mareeva AA
    Anesteziol Reanimatol; 2013; (1):34-7. PubMed ID: 23808251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.
    Gijsenbergh F; Ramael S; Houwing N; van Iersel T
    Anesthesiology; 2005 Oct; 103(4):695-703. PubMed ID: 16192761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 11. Sugammadex: a revolutionary approach to neuromuscular antagonism.
    Kopman AF
    Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954
    [No Abstract]   [Full Text] [Related]  

  • 12. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex: restricted vs unrestricted or selective vs non-selective?
    Gibbs NM; Kam PC
    Anaesth Intensive Care; 2012 Mar; 40(2):213-5. PubMed ID: 22417015
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case-Report: Reversal of a deep neuromuscular block with sugammadex after rapid sequence induction with high-dose rocuronium bromide].
    Adam C; Standl T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Oct; 45(10):614-6. PubMed ID: 20960365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal rocuronium sensitivity after titrated intraoperative sugammadex.
    McLoughlin PD
    Anaesth Intensive Care; 2012 Mar; 40(2):352. PubMed ID: 22417037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.